# Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment

> **NCT03540355** · PHASE3 · COMPLETED · sponsor: **EMS** · enrollment: 406 (actual)

## Conditions studied

- Dyslipidemias

## Interventions

- **DRUG:** Cipros 20 association
- **DRUG:** Crestor 20 mg

## Key facts

- **NCT ID:** NCT03540355
- **Lead sponsor:** EMS
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-02
- **Primary completion:** 2025-01-23
- **Final completion:** 2025-01-23
- **Target enrollment:** 406 (ACTUAL)
- **Last updated:** 2026-01-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03540355

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03540355, "Efficacy and Safety of Cipros 20 Association on Dyslipidemia Treatment". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03540355. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*